# Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda Consumption

> **NCT06110078** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **University of Arizona** · enrollment: 44 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT06110078
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-01-18
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06110078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06110078, "Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda Consumption". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06110078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*